Related Experiment Video
Updated: Mar 17, 2026
11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.9K
RGS1 expression is associated with poor prognosis in multiple myeloma
Jin Roh1, Su-Jin Shin1,2, A-Neum Lee3,4
1Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Journal of Clinical Pathology
|July 23, 2016
Summary
Regulator of G-protein signalling 1 (RGS1) protein expression in multiple myeloma (MM) patients indicates poor survival. High RGS1 levels serve as a prognostic marker for risk stratification and potential therapeutic targeting in MM.
Area of Science:
- Oncology
- Molecular Biology
- Hematology
Background:
- Multiple myeloma (MM) is a heterogeneous cancer with variable patient outcomes.
- Accurate risk stratification is essential for effective MM treatment decisions.
- Currently, no immunohistochemical markers are established for MM prognosis or prediction.
Purpose of the Study:
- To investigate the prognostic value of Regulator of G-protein signalling 1 (RGS1) expression in patients with multiple myeloma.
- To explore RGS1 as a potential immunohistochemical marker for MM risk stratification.
Main Methods:
- Evaluated RGS1 protein expression in 79 bone marrow biopsies from MM patients (2008-2010).
- Correlated RGS1 expression with various clinicopathological factors.
- Utilized immunohistochemistry for protein expression analysis.
Main Results:
- High RGS1 protein expression was significantly associated with poorer overall survival (p=0.005).
- Multivariable analysis confirmed high RGS1 expression (p=0.010) as a predictor of poor outcomes.
- High International Myeloma Working Group risk and elevated lactate dehydrogenase levels also correlated with adverse outcomes.
Conclusions:
- RGS1 expression shows potential as a prognostic marker for multiple myeloma.
- RGS1 may aid in risk stratification for MM patients.
- RGS1 represents a promising therapeutic target for novel MM treatments.
More Related Videos
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
6.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.6K
02:23Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
01:20The Retinoblastoma Gene
4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
02:38The Ras Gene
7.5K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.5K